9 April 2021
Itaconix plc
("Itaconix" or “the Company”)
Issue of Shares Under Contingent Consideration Plan, Director/PDMR dealings
Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable specialty polymers, announces that application has been made for the admission to trading on AIM of 1,923,389 new ordinary shares of 1 pence each in the Company (“Ordinary Shares”) (the “Application”).
The Application is to satisfy a contingent consideration payment in respect of the Company's acquisition of Itaconix Corporation announced on 20 June 2016 and has been calculated in accordance with the terms of the Merger Agreement as varied and announced on 12 July 2018.
Pursuant to the Application, shares have been issued to certain PDMRs of the Company as set out below:
| PDMR | Title | Number of Ordinary Shares received | Resulting Interested in Ordinary Shares % |
| John R. Shaw | CEO | 884,953 | 10.4% |
| Dr. Yvon G. Durant | CTO | 205,802 | 0.8% |
Application has been made for the admission to trading on AIM of these 1,923,389 Ordinary Shares, which is expected to occur on 12 April 2021. Following admission, the Company will have 434,371,642 Ordinary Shares in issue with each Ordinary Share carrying the right to one vote. The total number of voting rights in the Company is therefore 434,371,642. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interests in, the Company under the FCA's Disclosure and Transparency Rules.
For full release, please download full news release.